Osiris Therapeutics, Inc. To Present At The 9th Annual JMP Securities Healthcare Conference
Published: Jun 20, 2014
Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell company focused on developing and marketing products in wound care, orthopedic and sports medicine markets, announced today that Lode Debrabandere, Ph.D., President and Chief Executive Officer, is scheduled to present at the 9th Annual JMP Securities Healthcare Conference on Wednesday, June 25, 2014 at 10:00 a.m. ET in New York City.
Help employers find you! Check out all the jobs and post your resume.